The organization aims to transform treatment by funding the most innovative lupus research, fostering scientific talent, and driving discovery toward better diagnostics, improved treatments and, ultimately, a cure for lupus
Clinical trials like SURMOUNT-1 have shown participants losing up to 22.5% of body weight at higher doses over 72 weeks
Pancreatic Inflammation & Potential Pancreatic Damage While GLP-1 receptor agonists (e.g., Ozempic, Wegovy, Mounjaro) are widely used and carry established warnings for acute pancreatitis, extensive large-scale studies show the overall absolute risk remains very low, and long-term data indicates they do not increase the lifetime risk of pancreatic damage for most patients Pancreatitis is a known risk of GLP-1 drugs, but long-term consequences are still being studied
Avoid vendors that market these products with dosing instructions for human consumption, health claims, or body transformation transformations
The most important factor is adherencechoosing a time that fits naturally into daily routines maximises treatment compliance and therapeutic benefit
By law, any form of bodily introduction of this product into humans or animals is strictly prohibited